Literature DB >> 13862807

Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus.

G W ASHCROFT, D F SHARMAN.   

Abstract

The effects of reserpine and imipramine on the concentration of indolyl compounds bearing an OR group in position 5 (5-OR indolyl compounds) in the cerebrospinal fluid and the caudate nucleus of the dog have been studied. Reserpine was shown to produce an increase in the concentration of these compounds in the cerebrospinal fluid. In the caudate nucleus reserpine produced a fall in the concentration of the basic 5-OR indolyl compounds accompanied by an equivalent increase in the concentration of acidic 5-OR indolyl compounds. No significant change in the concentration of 5-OR indolyl compounds in the cerebrospinal fluid was observed after treatment with imipramine.

Entities:  

Keywords:  GANGLIA, BASAL/chemistry; IMIPRAMINE/pharmacology; INDOLES/chemistry; RESERPINE/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 13862807      PMCID: PMC1482248          DOI: 10.1111/j.1476-5381.1962.tb01436.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  9 in total

1.  Purification and properties of hydroxyindole-O-methyl transferase.

Authors:  J AXELROD; H WEISSBACH
Journal:  J Biol Chem       Date:  1961-01       Impact factor: 5.157

2.  The role of serotonin in neurobiology.

Authors:  E COSTA
Journal:  Int Rev Neurobiol       Date:  1960       Impact factor: 3.230

3.  5-Hydroxyindoles in human cerebrospinal fluids.

Authors:  G W ASHCROFT; D F SHARMAN
Journal:  Nature       Date:  1960-06-25       Impact factor: 49.962

4.  Evidence that tranquilizing action of reserpine is associated with change in brain serotonin and not in brain norepinephrine.

Authors:  B B BRODIE; K F FINGER; F B ORLANS; G P QUINN; F SULSER
Journal:  J Pharmacol Exp Ther       Date:  1960-07       Impact factor: 4.030

5.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.

Authors:  S UDENFRIEND; E TITUS; H WEISSBACH
Journal:  J Biol Chem       Date:  1955-10       Impact factor: 5.157

6.  The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain.

Authors:  M K PAASONEN; M VOGT
Journal:  J Physiol       Date:  1956-03-28       Impact factor: 5.182

7.  Identification and assay of serotonin in brain.

Authors:  D F BOGDANSKI; A PLETSCHER; B B BRODIE; S UNDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

8.  Fluorescence characteristics of 5-hydroxytryptamine (serotonin).

Authors:  S UDENFRIEND; D F BOGDANSKI; H WEISSBACH
Journal:  Science       Date:  1955-11-18       Impact factor: 47.728

9.  The effect of iproniazid and imipramine on the blood platelet 5-hydroxytrptamine level in man.

Authors:  E F MARSHALL; G S STIRLING; A C TAIT; A TODRICK
Journal:  Br J Pharmacol Chemother       Date:  1960-03
  9 in total
  28 in total

1.  THE EFFECT OF PRENYLAMINE ON THE METABOLISM OF CATECHOL AMINES AND 5-HYDROXYTRYPTAMINE IN BRAIN AND ADRENAL MEDULLA.

Authors:  A V JUORIO; M VOGT
Journal:  Br J Pharmacol Chemother       Date:  1965-04

2.  MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-06

3.  The action of 2-amino-tetralin (beta-tetrahydronaphthylamine) on the metabolism of 5-hydroxytryptamine in the brain of the mouse.

Authors:  D Robinson; D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1967-03

4.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

5.  Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

6.  The balance of biogenic amines as condition for normal behaviour.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

7.  On the effect of amantadine on monoamines and their metabolites in the brain and cerebrospinal fluid.

Authors:  U K Rinne; V Sonninen; M Hyyppä
Journal:  Experientia       Date:  1972-01-15

8.  Monoamines and their metabolites in the avian brain.

Authors:  A V Juorio; M Vogt
Journal:  J Physiol       Date:  1967-04       Impact factor: 5.182

9.  Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system.

Authors:  R Laverty; K M Taylor
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

10.  Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution.

Authors:  M Rössle; M Luft; R Herz; B Klein; M Lehmann; W Gerok
Journal:  Klin Wochenschr       Date:  1984-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.